206 related articles for article (PubMed ID: 21371895)
1. Synthesis, biological evaluation and 3D-QSAR studies of 3-keto salicylic acid chalcones and related amides as novel HIV-1 integrase inhibitors.
Sharma H; Patil S; Sanchez TW; Neamati N; Schinazi RF; Buolamwini JK
Bioorg Med Chem; 2011 Mar; 19(6):2030-45. PubMed ID: 21371895
[TBL] [Abstract][Full Text] [Related]
2. Homology model-guided 3D-QSAR studies of HIV-1 integrase inhibitors.
Sharma H; Cheng X; Buolamwini JK
J Chem Inf Model; 2012 Feb; 52(2):515-44. PubMed ID: 22256860
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological activity of aromatic diketone derivatives as HIV-1 integrase inhibitors.
Hu L; Li Z; Wang Z; Liu G; He X; Wang X; Zeng C
Med Chem; 2015; 11(2):180-7. PubMed ID: 25173788
[TBL] [Abstract][Full Text] [Related]
4. 3D-QSAR studies of quinoline ring derivatives as HIV-1 integrase inhibitors.
Sun XH; Guan JQ; Tan JJ; Liu C; Wang CX
SAR QSAR Environ Res; 2012 Oct; 23(7-8):683-703. PubMed ID: 22991976
[TBL] [Abstract][Full Text] [Related]
5. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
Lu P; Wei X; Zhang R
Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
[TBL] [Abstract][Full Text] [Related]
6. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells.
Monserrat JP; Al-Safi RI; Tiwari KN; Quentin L; Chabot GG; Vessières A; Jaouen G; Neamati N; Hillard EA
Bioorg Med Chem Lett; 2011 Oct; 21(20):6195-7. PubMed ID: 21889342
[TBL] [Abstract][Full Text] [Related]
7. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
[TBL] [Abstract][Full Text] [Related]
8. Amide-containing diketoacids as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.
Li H; Wang C; Sanchez T; Tan Y; Jiang C; Neamati N; Zhao G
Bioorg Med Chem; 2009 Apr; 17(7):2913-9. PubMed ID: 19269185
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
Naidu BN; Sorenson ME; Patel M; Ueda Y; Banville J; Beaulieu F; Bollini S; Dicker IB; Higley H; Lin Z; Pajor L; Parker DD; Terry BJ; Zheng M; Martel A; Meanwell NA; Krystal M; Walker MA
Bioorg Med Chem Lett; 2015 Feb; 25(3):717-20. PubMed ID: 25529736
[TBL] [Abstract][Full Text] [Related]
10. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.
Barreca ML; Ferro S; Rao A; De Luca L; Zappalà M; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
J Med Chem; 2005 Nov; 48(22):7084-8. PubMed ID: 16250669
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel 5(H)-phenanthridin-6-ones, 5(H)-phenanthridin-6-one diketo acid, and polycyclic aromatic diketo acid analogs as new HIV-1 integrase inhibitors.
Patil S; Kamath S; Sanchez T; Neamati N; Schinazi RF; Buolamwini JK
Bioorg Med Chem; 2007 Feb; 15(3):1212-28. PubMed ID: 17158051
[TBL] [Abstract][Full Text] [Related]
13. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
14. Docking-based CoMFA and CoMSIA study of azaindole carboxylic acid derivatives as promising HIV-1 integrase inhibitors.
Yu S; Wang P; Li Y; Liu Y; Zhao G
SAR QSAR Environ Res; 2013 Oct; 24(10):819-39. PubMed ID: 23988186
[TBL] [Abstract][Full Text] [Related]
15. Computational modeling methods for QSAR studies on HIV-1 integrase inhibitors (2005-2010).
Ko GM; Reddy AS; Garg R; Kumar S; Hadaegh AR
Curr Comput Aided Drug Des; 2012 Dec; 8(4):255-70. PubMed ID: 22242796
[TBL] [Abstract][Full Text] [Related]
16. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
17. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.
Serafin K; Mazur P; Bak A; Laine E; Tchertanov L; Mouscadet JF; Polanski J
Bioorg Med Chem; 2011 Aug; 19(16):5000-5. PubMed ID: 21767953
[TBL] [Abstract][Full Text] [Related]
18. Combined ligand and structure-based approaches on HIV-1 integrase strand transfer inhibitors.
Reddy KK; Singh SK
Chem Biol Interact; 2014 Jul; 218():71-81. PubMed ID: 24792351
[TBL] [Abstract][Full Text] [Related]
19. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
Buolamwini JK; Assefa H
J Med Chem; 2002 Feb; 45(4):841-52. PubMed ID: 11831895
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors.
Reddy KK; Singh SK; Dessalew N; Tripathi SK; Selvaraj C
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):339-47. PubMed ID: 21699459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
